How to value technological innovation: A proposal for determining relative clinical value

Gastroenterology

Volumn 144, Issue 1, 2013, Pages 5-8

  Ladabaum, Uri ^a   Brill, Joel V ^b   Sonnenberg, Amnon ^c   Shaheen, Nicholas J ^d   Inadomi, John ^e   Wilcox, C Mel ^f   Park, Walter G ^a   Hur, Chin ^g   Pasricha, Pankaj J ^h  

^a STANFORD UNIVERSITY   (United States)

^b Predictive Health LLC   (United States)

^c OREGON HEALTH AND SCIENCE UNIVERSITY   (United States)

^d UNIVERSITY OF NORTH CAROLINA   (United States)

^e UNIVERSITY OF WASHINGTON   (United States)

^f UNIVERSITY OF ALABAMA AT BIRMINGHAM   (United States)

^g MASSACHUSETTS GENERAL HOSPITAL   (United States)

^h JOHNS HOPKINS UNIVERSITY   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

COMPETITION; COST BENEFIT ANALYSIS; DECISION MAKING; DEVICE APPROVAL; DIAGNOSTIC VALUE; DIGESTIVE TRACT ENDOSCOPY; GASTROENTEROLOGY; GASTROESOPHAGEAL REFLUX; MARKETING; MEDICAL TECHNOLOGY; NOTE; PRIORITY JOURNAL; PRODUCT SAFETY; REIMBURSEMENT; STOMACH FUNDOPLICATION;

EID: 84871277588     PISSN: 00165085     EISSN: 15280012     Source Type: Journal    
DOI: 10.1053/j.gastro.2012.11.006     Document Type: Editorial

References (20)

1. American Medical Association. Current procedural terminology (CPT®). Chicago
2. M.R. Gold, J.E. Siegel, L.B. Russell Cost-effectiveness in health and medicine 1996 Oxford University Press Oxford
3. L.B. Russell, M.R. Gold, J.E. Siegel The role of cost-effectiveness analysis in health and medicine Panel on Cost-Effectiveness in Health and Medicine JAMA 276 1996 1172 1177
4. J.E. Siegel, M.C. Weinstein, L.B. Russell Recommendations for reporting cost-effectiveness analyses Panel on Cost-Effectiveness in Health and Medicine JAMA 276 1996 1339 1341
5. M.C. Weinstein, J.E. Siegel, M.R. Gold Recommendations of the Panel on Cost-effectiveness in Health and Medicine JAMA 276 1996 1253 1258
6. S. Bryan, L. Gold, R. Sheldon Preference measurement using conjoint methods: an empirical investigation of reliability Health Econ 9 2000 385 395
7. S.T. Hawley, R.J. Volk, P. Krishnamurthy Preferences for colorectal cancer screening among racially/ethnically diverse primary care patients Med Care 46 2008 S10 S16
8. D.A. Marshall, F.R. Johnson, K.A. Phillips Measuring patient preferences for colorectal cancer screening using a choice-format survey Value Health 10 2007 415 430
9. K.A. Phillips, F.R. Johnson, T. Maddala Measuring what people value: a comparison of "attitude" and "preference" surveys Health Serv Res 37 2002 1659 1679
10. K.A. Phillips, T. Maddala, F.R. Johnson Measuring preferences for health care interventions using conjoint analysis: an application to HIV testing Health Serv Res 37 2002 1681 1705
11. A.H. Pieterse, F. Berkers, M.C. Baas-Thijssen Adaptive conjoint analysis as individual preference assessment tool: feasibility through the internet and reliability of preferences Patient Educ Couns 78 2010 224 233
12. M. Ryan, S. Farrar Using conjoint analysis to elicit preferences for health care BMJ 320 2000 1530 1533
13. M. Ryan, E. McIntosh, P. Shackley Using conjoint analysis to elicit the views of health service users: an application to the patient health card Health Expect 1 1998 117 129
14. M. Ryan, E. McIntosh, P. Shackley Methodological issues in the application of conjoint analysis in health care Health Econ 7 1998 373 378
15. S.R. Tunis, S.D. Pearson Coverage options for promising technologies: Medicare's 'coverage with evidence development' Health Aff (Millwood) 25 2006 1218 1230
16. M.J. Lindsay, B.A. Siegel, S.R. Tunis The National Oncologic PET Registry: expanded medicare coverage for PET under coverage with evidence development AJR Am J Roentgenol 188 2007 1109 1113
17. S.R. Tunis, K. Chalkidou Coverage with evidence development: a very good beginning, but much to be done Commentary to Hutton et al Int J Technol Assess Health Care 23 2007 432 435
18. P.E. Mohr, S.R. Tunis Access with evidence development: the US experience Pharmacoeconomics 28 2010 153 162
19. C.D. Mullins, R. Montgomery, S. Tunis Uncertainty in assessing value of oncology treatments Oncologist 15 Suppl 1 2010 58 64
20. S. Tunis, D. Whicher The National Oncologic PET Registry: lessons learned for coverage with evidence development J Am Coll Radiol 6 2009 360 365